REG - Synectics PLC - Director/PDMR Shareholding

SynecticsAnnouncement

01/10/2021 14:15

RNS Number : 7847N
  
Synectics PLC
  
01 October 2021
  
 

 



 
RNS 


 
1 October 2021



 
 
 
Synectics plc
("Synectics" or the "Company")
 
Director/PDMR dealings
 
Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, has been notified that earlier today, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 14,843 ordinary shares of 20 pence each in the Company at a price of £1.05 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2021.
 
Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per share at the beginning of the Period which was £1.35.
 
As a result of this purchase, the Company has been notified that the following Executive Directors and PDMRs have acquired the following interests in shares of the Company:
 



Name


Position


Status


Number of Shares purchased by the Trustee




Paul Webb


Chief Executive


Executive Director


857




David Bedford


Finance Director


Executive Director


857




Greg Alcorn


Divisional Director


PDMR


857




David Lowe


Divisional Director


PDMR


857



 
In addition, David Bedford, Finance Director of the Company has notified the Company that he too purchased 5,000 ordinary shares of 20p each in the Company at £1.05 per share earlier today.
 
Following these purchases, the interests of Messrs Webb, Bedford, Alcorn and Lowe in the shares of the Company are as follows:
 



Name


Shares Held


Interest in Shares in Share Schemes


Resultant Total Interest


% of Issued Share Capital




Paul Webb


57,115


536,327


593,442


3.33%




David Bedford


20,000


186,857


206,857


1.16%




Greg Alcorn


-


25,655


25,655


0.14%




David Lowe


15,000


43,177


58,177


0.33%



 
 
 
For further information, please contact:



Synectics plc


Tel: +44 (0) 114 280 2828




Claire Stewart, Company Secretary








email: legalandsecretarial@synecticsplc.com 


www.synecticsplc.com














Shore Capital


Tel: +44 (0) 20 7408 4050




Tom Griffiths / David Coaten / Henry Willcocks
 







 
 Ends
 
About Synectics plc
 
Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.
 
Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.
 
Find out more at www.synecticsplc.com
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHEADEFEFLFFFA